Discover · The Research Behind It

Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits — Brenton et al., J Neurol Neurosurg Psychiatry 2022

Last checked

  • Free
  • Worldwide
  • Research paper
  • Reading
  • Online
Published in
Journal of Neurology, Neurosurgery & Psychiatry, 2022
Evidence
Early
Cost
Free.

What is this paper about?

65 adults with stable relapsing MS followed a modified Atkins ketogenic diet for 6 months; 83% kept to it, checked with daily urine ketone strips. Fatigue (MFIS) fell by about 14 points and depression (BDI) by about 4, quality-of-life scores rose by 11–12 points, the 6-minute walk improved by 78 feet and fat mass fell by 7.7 kg. Constipation and diarrhoea were the commonest side effects; no relapses were reported.

Why is it in the directory?

Backs up the ketogenic-therapy practitioners and societies in chapter 01 and Ketogenic Diet India in chapter 14, which covers MS. It tested a modified Atkins ketogenic diet, not the Wahls Protocol or Overcoming MS (a low-saturated-fat diet). For people with relapsing MS.

Is it free to read?

Single-arm phase II trial — 65 adults with relapsing MS on a modified Atkins ketogenic diet for 6 months. Early evidence. J Neurol Neurosurg Psychiatry 2022;93(6):637-644. DOI 10.1136/jnnp-2022-329074. Free full text in PubMed Central (PMC9350909).

About the paper

Authors
Brenton JN, Lehner-Gulotta D, Woolbright E, et al.
Published in
J Neurol Neurosurg Psychiatry 2022;93(6):637-644
Kind of study
Single-arm phase II trial — 65 adults with relapsing MS on a modified Atkins ketogenic diet for 6 months
Strength of evidence
Early — promising findings that still need confirming
Free to read
Free in PMC (author manuscript, NIH public access)

Good to know

  • No control group and mostly self-reported outcomes; the authors say it was not designed to show the diet works, which needs a randomised trial.

Where it sits in the directory

Listed under “Metabolic Psychiatry & Brain Health — Ketogenic Therapy for Mental Illness, Epilepsy & Neurological Conditions” in chapter 17 of the directory, The Research Behind It, with 12 other listings in the same category.

See every listing in “Metabolic Psychiatry & Brain Health”

Similar listings

Also in the directory, with why each one is here.

Browse all 280 in The Research Behind It

This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.